Glenmark, Alembic Pharmaceuticals, and Sun Pharma are recalling various products in the US due to manufacturing issues, according to the USFDA. Glenmark is recalling Carvedilol tablets due to nitrosamine impurity and Theophylline tablets for failed dissolution. Alembic is recalling Doxepin capsules for a similar impurity issue, while Sun Pharma recalls Spironolactone tablets due to aluminum contamination.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/82y5NSr
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA
0 comments:
Post a Comment